Ovarian dysgerminoma: a therapeutic challenge.
Dysgerminoma remains a rare but quite interesting tumor. Over the last 40 years, the prognosis has markedly improved with a 5 year survival increasing from around 30% to more than 80%. Precise diagnosis and adequate staging are mandatory to define the best treatment approach aiming to cure the woman, while preserving her quality of life (ovarian function and fertility).